The Role of Fibrate Treatment in Dyslipidemia: An Overview

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|17|3124-3131

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.17, 2013-05, pp. : 3124-3131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus

By Reyes-Soffer Gissette   Rondon-Clavo Carlos   Ginsberg Henry N  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1429-1438

Informa Healthcare

Access to resources Recommend Favorite

Emerging Targets for the Treatment of Dyslipidemia

By  

Current Medicinal Chemistry, Vol. 18, Iss. 6, 2011-02 ,pp. : 909-922

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense Oligonucleotides for the Treatment of Dyslipidemia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 950-960

Bentham Science Publishers

Access to resources Recommend Favorite

Etanercept: an overview of its role in the treatment of psoriasis

By Galindo Malini Patel   Bartlett Brenda L   Gewirtzman Aron   Mendoza Natalia   Tremaine Anne Marie   Tyring Stephen K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 3, 2008-03 ,pp. : 305-310

Informa Healthcare

Access to resources Recommend Favorite

Role of antioxidants in treatment of male infertility: an overview of the literature

By Agarwal Ashok   Nallella Kiran P   Allamaneni Shyam SR   Said Tamer M  

Reproductive BioMedicine Online, Vol. 8, Iss. 6, 2004-06 ,pp. : 616-627

Reproductive Healthcare Ltd

Access to resources Recommend Favorite